ISRG Stock Cash Flow Statements

Intuitive Surgical Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Intuitive Surgical Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30

operating activities:
net income	664,200,000	703,700,000	688,000,000	570,600,000	531,500,000	547,400,000	610,700,000	419,800,000	426,000,000	360,800,000	336,700,000	324,700,000	313,600,000	369,400,000	382,700,000	387,200,000	523,000,000	435,200,000	363,600,000	316,800,000	70,200,000	316,200,000	362,700,000	398,700,000	316,400,000	304,000,000	291,300,000	291,800,000	254,600,000	287,300,000	-38,800,000	297,500,000	221,500,000	179,800,000	204,000,000	211,000,000	184,500,000	136,400,000	190,000,000	167,300,000	134,500,000	97,000,000	146,800,000	123,700,000	104,000,000	44,300,000	166,200,000	156,800,000	159,100,000	188,900,000	174,900,000	183,300,000	154,900,000	143,500,000		122,400,000	117,400,000	104,100,000	121,200,000	86,600,000	88,700,000	85,300,000	77,552,000	64,524,000	62,388,000	28,142,000	50,758,000	57,594,000	51,182,000	44,781,000	49,153,000	40,919,000	30,663,000	23,802,000	23,641,000	17,263,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and loss on disposal of property, plant, and equipment	152,100,000	137,500,000	121,600,000	112,700,000	106,800,000	104,200,000	118,100,000	103,500,000	92,300,000	87,700,000	98,600,000	81,900,000	79,800,000	77,700,000	74,300,000	75,700,000	68,000,000	64,800,000	67,300,000	56,600,000	51,400,000	51,100,000	52,000,000	40,200,000	36,200,000	31,600,000	31,800,000	27,000,000	26,100,000	23,700,000	24,800,000	21,800,000	20,600,000	19,000,000	19,900,000	18,000,000	17,700,000	18,300,000
amortization of intangible assets	3,200,000	3,400,000	3,100,000	3,500,000	5,000,000	5,100,000	5,100,000	5,100,000	5,000,000	5,000,000	7,600,000	7,900,000	6,200,000	6,100,000	6,600,000	6,300,000	7,600,000	6,900,000	12,500,000	12,600,000	12,400,000	12,300,000	11,800,000	10,700,000	10,500,000	10,000,000	4,500,000	4,000,000	3,100,000	2,600,000	2,800,000	3,100,000	3,300,000	3,700,000	4,200,000	4,300,000	4,600,000	5,100,000	5,800,000	6,200,000	6,200,000	6,200,000	6,500,000	6,500,000	4,700,000	4,700,000	4,700,000	5,300,000	5,700,000	5,600,000	5,900,000	5,200,000	6,200,000	5,800,000		4,400,000	4,300,000	4,400,000	4,500,000	4,300,000	4,000,000	3,900,000	3,881,000	3,880,000	4,085,000	3,772,000	3,559,000	2,817,000	2,586,000	1,489,000	726,000	431,000	430,000	429,000	430,000	429,000
gain on investments, accretion of discounts, and amortization of premiums on investments	-9,700,000	-17,700,000		-12,300,000	-20,000,000	-5,900,000
deferred income taxes	-29,500,000	100,000	-30,800,000	-64,700,000	-32,600,000	-7,200,000	-219,800,000	-43,300,000	-27,000,000	9,300,000	-83,300,000	-61,900,000	-25,700,000	-14,400,000	-22,000,000	-16,600,000	-68,700,000	44,700,000	-14,300,000	19,400,000	-12,000,000	64,500,000	300,000	-61,000,000	19,800,000	32,900,000	-20,400,000	3,600,000	11,300,000	37,400,000	34,100,000	-5,000,000	4,100,000	29,700,000	-13,000,000	-4,100,000	6,900,000	28,900,000	1,800,000	7,500,000	-6,800,000	2,100,000	5,200,000	6,800,000	-13,800,000	-33,200,000	-4,700,000	-18,100,000	-6,200,000	-9,500,000	-1,500,000	-13,200,000	-4,700,000	-1,400,000		7,400,000	-7,400,000	8,200,000	-9,700,000	-12,200,000	-4,600,000	5,000,000	-137,000	-7,091,000	-5,948,000	-2,469,000	-6,380,000	-6,515,000	-4,981,000	-2,619,000	9,257,000	-1,437,000	-3,186,000	-721,000	-1,223,000	-2,591,000
share-based compensation expense	196,200,000	185,200,000	177,000,000	172,900,000	173,600,000	153,300,000	150,400,000	156,100,000	146,500,000	139,800,000	127,600,000	138,100,000	126,700,000	120,800,000	117,800,000	120,100,000	108,100,000	103,200,000	103,100,000	105,800,000	95,900,000	90,600,000	89,200,000	88,900,000	81,600,000	76,100,000	70,400,000	70,000,000	63,300,000	57,500,000	55,600,000	55,700,000	50,400,000	47,400,000	45,500,000	46,800,000	42,600,000	42,700,000	41,300,000	44,200,000	41,300,000	41,100,000	41,100,000	45,100,000	41,900,000	40,800,000	41,600,000	50,400,000						34,400,000		34,900,000	34,800,000	32,100,000		30,400,000	30,300,000	26,800,000		24,597,000	24,649,000	22,733,000		20,965,000	19,718,000	14,564,000		8,726,000	9,351,000	8,105,000
amortization of contract acquisition assets	9,100,000	8,700,000	10,700,000	9,400,000	9,100,000	8,500,000	10,400,000	7,700,000	7,500,000	7,400,000	5,900,000	7,100,000	7,000,000	6,600,000	6,500,000	5,500,000	5,100,000	4,900,000	4,700,000	4,200,000	4,100,000	4,100,000	3,900,000
changes in operating assets and liabilities, net of effects of acquisitions:
accounts receivable	-47,700,000	3,600,000	-74,100,000	-42,800,000	18,800,000	2,200,000	-166,600,000	-59,000,000	22,400,000	16,900,000	-92,100,000	-11,200,000	67,400,000	-123,400,000	-87,600,000	4,900,000	-45,300,000	-14,300,000	-51,500,000	-79,700,000	18,700,000	118,200,000	-11,800,000	1,700,000	-85,700,000	134,600,000	-96,100,000	-47,900,000	-50,300,000	33,000,000	-43,900,000	13,100,000	-68,200,000	17,300,000	1,800,000	-28,300,000	-77,800,000	68,400,000	-59,500,000	-13,300,000	-29,100,000	22,700,000	-56,100,000	12,100,000	-32,100,000	62,400,000	-20,800,000	78,000,000	-13,600,000	25,300,000	-34,100,000	-12,900,000	-23,500,000	1,600,000	-32,900,000	-14,700,000	9,600,000	-13,100,000	-39,100,000	-13,100,000	-14,500,000	25,200,000	-18,855,000	-11,312,000	-35,875,000	30,767,000	3,600,000	-11,627,000	-26,399,000	-5,314,000	-10,103,000	-14,617,000	-15,167,000	4,200,000	-23,003,000	-1,140,000
inventory	-283,100,000	-211,100,000	-179,100,000	-261,500,000	-209,800,000	-179,600,000	-184,300,000	-239,600,000	-161,500,000	-127,100,000	-127,500,000	-173,600,000	-125,400,000	-120,100,000	-66,800,000	-96,800,000	-51,200,000	-41,200,000	6,900,000	-56,900,000	-54,900,000	-65,200,000	-67,100,000	-115,400,000	-84,000,000	-94,000,000	-73,200,000	-71,900,000	-67,700,000	-66,200,000	-32,800,000	-24,400,000	-19,300,000	-39,000,000	-5,900,000	-21,300,000	-11,700,000	-7,800,000													4,300,000	-6,400,000	-500,000	-4,500,000		-8,500,000	-6,800,000	-6,500,000	-1,800,000	-11,000,000	-5,500,000	-10,900,000	-954,000	2,602,000	5,135,000	-923,000	-10,962,000	-9,904,000	-3,761,000	-6,437,000	-5,769,000	-2,734,000	2,221,000	-1,931,000	-1,965,000	2,300,000
prepaids and other assets	-134,000,000	-7,800,000	-152,200,000	32,100,000	-107,600,000	-4,100,000	-13,300,000	51,300,000	13,500,000	-27,300,000	-32,400,000	-6,700,000	-68,400,000	-21,700,000	11,800,000	-39,700,000	-103,800,000	-73,200,000	7,000,000	-23,300,000	36,400,000	-131,900,000	-21,800,000	-5,900,000	-26,500,000	-62,700,000	11,600,000	13,100,000	-81,800,000	-20,600,000	-14,900,000	32,700,000	-48,000,000	1,700,000	-9,700,000	-4,500,000	35,400,000	-49,900,000	30,600,000	-59,300,000	9,000,000	9,200,000	1,800,000	-49,600,000	5,300,000	-25,100,000	-14,700,000	-6,400,000	-2,400,000	18,500,000	-31,600,000	-1,100,000	-1,000,000	-3,400,000	-1,800,000	-4,500,000	15,200,000	-18,300,000	1,400,000	-1,100,000	-1,200,000	2,000,000	609,000	-2,969,000	-2,529,000	-1,427,000	1,786,000	-2,236,000	5,331,000	-915,000	884,000	-2,445,000	-4,165,000	-1,045,000	2,064,000	-311,000
accounts payable	-10,700,000	83,100,000	-21,600,000	22,800,000	5,900,000	-7,500,000	14,000,000	-8,800,000	19,600,000	16,900,000	-5,000,000	13,900,000	14,300,000	-1,900,000	200,000	-2,400,000	14,500,000	23,700,000	-28,400,000	-300,000	-25,500,000	21,900,000	-12,400,000	3,000,000	-1,300,000	23,000,000	3,300,000	-900,000	5,900,000	8,400,000	2,100,000	6,200,000	200,000	5,500,000	9,500,000	-6,600,000	7,700,000	5,300,000	-2,900,000	-7,000,000	-4,100,000	2,700,000	9,500,000	-5,900,000	3,800,000	10,300,000	-13,300,000	-5,300,000	-600,000	10,300,000	1,500,000	1,500,000	4,900,000	500,000		5,700,000	-5,700,000	7,500,000	-100,000	-6,100,000	7,300,000	7,000,000	2,657,000	-1,643,000	5,242,000	784,000	-5,634,000	6,223,000	-4,023,000	-5,805,000	7,518,000	6,019,000	1,937,000	3,172,000	890,000	4,416,000
accrued compensation and employee benefits	111,100,000	-226,000,000	158,200,000	56,200,000	156,100,000	-271,200,000	61,600,000	28,200,000	85,600,000	-140,600,000	93,400,000	29,600,000	58,800,000	-130,300,000	84,800,000	11,300,000	59,200,000	-40,200,000	59,800,000	6,600,000	12,200,000	-95,200,000	64,200,000	26,500,000	35,400,000	-68,700,000	47,700,000	18,100,000	24,400,000	-64,000,000	42,500,000	13,600,000	25,400,000	-50,300,000	31,600,000	9,700,000	17,100,000	-39,700,000	26,600,000	3,500,000	18,000,000	-26,600,000	18,600,000	1,600,000	19,200,000	-18,000,000	15,800,000	-15,100,000	4,000,000	-38,000,000	29,100,000	300,000	16,800,000	-25,200,000			11,200,000	-20,200,000			11,600,000	-19,100,000			7,340,000	-14,962,000			8,542,000	-11,843,000			6,502,000	-7,131,000
deferred revenue	11,800,000	37,000,000	37,300,000	8,200,000	-10,300,000	-4,000,000	54,400,000	-13,200,000	-12,000,000	24,200,000	42,700,000	-18,100,000	-14,500,000	11,400,000	30,300,000	-8,300,000	3,800,000	6,800,000	24,200,000	-13,300,000	3,300,000	800,000	29,700,000	-2,900,000	9,200,000	-500,000	19,600,000	4,900,000	18,400,000	11,400,000	7,700,000	-2,900,000	11,300,000	36,700,000	14,000,000	2,100,000	3,500,000	300,000	600,000	5,500,000	6,600,000	-4,500,000									14,200,000	3,400,000	7,500,000	5,400,000		9,200,000	3,800,000	4,700,000	9,300,000	8,900,000	4,500,000	3,800,000	8,891,000	2,134,000	-8,761,000	19,051,000	6,450,000	6,748,000	5,921,000	5,440,000	6,122,000	5,177,000	3,419,000	2,588,000	3,269,000	3,341,000
other liabilities	82,400,000	-118,100,000	90,700,000	99,400,000	-6,000,000	-75,800,000	-205,000,000	140,300,000	38,300,000	-6,500,000	60,100,000	41,900,000	-900,000	20,600,000	16,400,000	52,000,000	14,100,000	-31,100,000	63,500,000	-12,100,000	20,300,000	-34,800,000	51,400,000	13,500,000	1,700,000	-54,700,000	46,300,000	6,900,000	21,600,000	-37,700,000	288,400,000	-62,900,000	9,900,000	-16,100,000	14,000,000	25,500,000	14,600,000	-300,000	6,200,000	2,800,000	-3,800,000	-15,700,000	-34,000,000	-4,700,000	19,800,000	82,300,000		-26,100,000	20,500,000	15,000,000
net cash from operating activities	715,400,000	581,600,000	822,600,000	706,500,000	620,500,000	265,400,000	228,300,000	548,400,000	665,700,000	371,400,000	437,900,000	383,200,000	446,700,000	223,000,000	567,700,000	501,400,000	542,700,000	477,600,000	627,500,000	274,600,000	229,900,000	352,800,000	552,700,000	396,300,000	316,000,000	333,200,000	338,100,000	319,800,000	231,500,000	280,200,000	332,000,000	353,900,000	216,500,000	241,500,000	325,100,000	259,600,000	249,700,000	208,500,000	283,400,000	179,700,000	185,100,000	123,700,000	194,200,000	150,600,000	154,000,000	166,300,000	229,100,000	203,800,000	189,100,000	258,000,000	217,200,000	214,000,000	216,500,000	166,500,000		151,600,000	196,000,000	100,300,000	123,900,000	113,000,000	175,500,000	115,600,000	115,637,000	96,305,000	82,989,000	90,124,000	102,240,000	71,810,000	64,801,000	39,384,000	83,012,000	48,954,000	40,352,000	33,369,000	27,926,000	36,078,000
capex	-155,300,000	-116,600,000	-312,000,000	-247,900,000	-309,400,000	-241,900,000	-435,500,000	-256,300,000	-178,300,000	-194,100,000	0	-169,100,000	-130,500,000	-95,100,000	-150,900,000	-68,300,000	-75,700,000	-58,600,000	-61,900,000	-64,400,000	-110,000,000	-105,200,000	-142,000,000	-86,700,000	-82,100,000	-114,800,000	0	-47,000,000	-44,800,000	-40,100,000	-31,000,000	-51,400,000	0	-53,000,000	0	-15,100,000	-11,400,000	-9,600,000	0	-28,500,000	0	-19,200,000	0	-13,800,000	0	-20,600,000	-28,900,000	-34,000,000	-25,000,000	-16,700,000	-88,700,000	0	-13,800,000	-49,800,000		-14,500,000	-38,500,000	-14,700,000	-9,400,000	-50,100,000	-20,300,000	-16,200,000	-7,722,000	-5,360,000	-12,854,000	-27,480,000	0	0	0	-6,949,000	-8,084,000	-5,069,000	-4,398,000	-2,705,000	-3,807,000	-2,072,000
free cash flows	560,100,000	465,000,000	510,600,000	458,600,000	311,100,000	23,500,000	-207,200,000	292,100,000	487,400,000	177,300,000	437,900,000	214,100,000	316,200,000	127,900,000	416,800,000	433,100,000	467,000,000	419,000,000	565,600,000	210,200,000	119,900,000	247,600,000	410,700,000	309,600,000	233,900,000	218,400,000	338,100,000	272,800,000	186,700,000	240,100,000	301,000,000	302,500,000	216,500,000	188,500,000	325,100,000	244,500,000	238,300,000	198,900,000	283,400,000	151,200,000	185,100,000	104,500,000	194,200,000	136,800,000	154,000,000	145,700,000	200,200,000	169,800,000	164,100,000	241,300,000	128,500,000	214,000,000	202,700,000	116,700,000		137,100,000	157,500,000	85,600,000	114,500,000	62,900,000	155,200,000	99,400,000	107,915,000	90,945,000	70,135,000	62,644,000	102,240,000	71,810,000	64,801,000	32,435,000	74,928,000	43,885,000	35,954,000	30,664,000	24,119,000	34,006,000
investing activities:
purchase of investments	-172,000,000	-519,800,000		-1,920,200,000	-883,500,000	-905,900,000	-1,387,200,000	-806,200,000	-10,500,000	-3,500,000	-5,900,000	-17,400,000	-188,900,000	-1,187,300,000	-1,238,300,000	-1,706,000,000	-1,674,600,000	-1,833,100,000	-1,269,700,000	-1,596,400,000	-736,800,000	-690,000,000	-802,800,000	-727,500,000	-823,600,000	-992,300,000	-887,900,000	-842,400,000	-417,900,000	-433,700,000	-872,900,000	-415,100,000	-538,800,000	-168,200,000	-688,900,000	-828,300,000	-580,600,000	-487,700,000	-699,200,000	-529,300,000	-316,400,000	-282,500,000	-341,100,000	-388,900,000	-181,400,000	-433,200,000	-313,700,000	-182,400,000	-371,600,000	-576,000,000	-385,100,000	-425,900,000	-376,600,000	-646,300,000		-450,100,000	-481,200,000	-244,700,000	-353,200,000	-427,900,000	-361,100,000	-243,200,000	-241,249,000	-219,978,000	-169,507,000	-133,717,000	-146,262,000	-168,940,000	-267,048,000	-150,448,000	-238,121,000	-187,336,000	-147,956,000	-114,932,000	-103,285,000	-76,180,000
proceeds from sales of investments			0	0	0	100,200,000	182,600,000	10,200,000	11,200,000	26,300,000	1,500,000				12,500,000	300,000	100,000	72,000,000	0	0	702,500,000	98,200,000	25,200,000	21,000,000	16,700,000	44,400,000	0	15,000,000	32,400,000	226,600,000	335,700,000	50,700,000	53,800,000	1,421,100,000	111,500,000	45,300,000	168,600,000	64,500,000	55,500,000	46,000,000	57,100,000	74,500,000	42,700,000	15,200,000	554,700,000	53,300,000	106,800,000	620,900,000	207,200,000	50,000,000	67,000,000	33,400,000	96,200,000	133,200,000
proceeds from maturities of investments	340,100,000	849,900,000	478,800,000	755,100,000	725,800,000	919,100,000	597,700,000	605,500,000	742,500,000	744,400,000	718,100,000	671,200,000	797,400,000	1,067,700,000	735,700,000	935,200,000	1,365,500,000	1,231,400,000	997,300,000	634,900,000	681,000,000	617,600,000	541,300,000	609,600,000	663,800,000	755,100,000	484,900,000	323,800,000	424,100,000	300,800,000	252,400,000	155,800,000	186,500,000	108,400,000	286,200,000	256,800,000	186,200,000	240,900,000	250,300,000	173,000,000	263,000,000	139,500,000	161,500,000	130,500,000	227,500,000	195,200,000	172,600,000	208,700,000	246,400,000	194,700,000	231,100,000	244,300,000	171,600,000	153,200,000
purchase of property, plant, and equipment	-155,300,000	-116,600,000	-312,000,000	-247,900,000	-309,400,000	-241,900,000	-435,500,000	-256,300,000	-178,300,000	-194,100,000
acquisition of businesses, net of cash, and intellectual property and other investing activities							-1,800,000	200,000
net cash from investing activities	260,700,000	213,500,000	-1,264,200,000	-1,413,000,000	-467,100,000	-128,500,000	-1,044,200,000	-446,600,000	557,600,000	573,100,000	574,800,000	544,500,000	466,200,000	-214,700,000	-641,000,000	-838,800,000	-384,700,000	-597,000,000	-334,300,000	-1,025,900,000	536,700,000	-117,100,000	-406,200,000	-216,600,000	-222,700,000	-308,900,000	-486,300,000	-572,600,000	-44,300,000	53,600,000	-315,800,000	-260,000,000	-353,800,000	1,308,300,000	-309,000,000	-541,300,000	-237,200,000	-191,900,000	-413,100,000	-338,800,000	-9,900,000	-87,700,000	-203,500,000	-258,700,000	513,600,000	-205,300,000	-63,200,000	613,200,000	57,000,000	-348,000,000	-133,100,000	-180,300,000	-122,600,000	-409,700,000		-164,800,000	-167,100,000	7,300,000	-103,100,000	-119,200,000	-106,600,000	-147,600,000	-141,153,000	-93,790,000	-14,092,000	-43,342,000	-138,307,000	-102,621,000	-97,342,000	33,742,000	-76,791,000	-67,948,000	-54,530,000	-37,131,000	-58,638,000	-27,241,000
financing activities:
proceeds from issuance of common stock relating to employee stock plans	49,400,000	134,300,000	61,900,000	115,600,000	71,500,000	180,400,000	44,100,000	77,400,000	74,600,000	100,200,000	45,200,000	82,000,000	26,600,000	80,000,000	31,700,000	91,100,000	69,700,000	84,000,000	40,900,000	113,900,000	62,700,000	91,300,000	67,100,000	86,100,000	30,800,000	88,800,000	37,000,000	64,700,000	48,700,000	86,200,000	33,900,000	85,200,000	127,300,000	169,100,000	30,500,000	101,900,000	189,700,000	258,800,000	67,100,000
taxes paid related to net share settlement of equity awards	-16,200,000	-370,100,000	-12,500,000	-17,400,000	-13,500,000	-226,600,000	-9,300,000	-14,800,000	-10,900,000	-129,700,000	-6,900,000	-8,300,000	-6,800,000	-172,200,000	-10,400,000	-13,300,000	-9,600,000	-178,300,000	-9,900,000	-10,200,000	-6,200,000	-148,900,000	-6,200,000	-7,900,000	-6,400,000	-138,600,000	-5,000,000	-7,000,000	-5,500,000	-102,500,000	-3,000,000	-3,600,000	-2,600,000	-47,400,000	-800,000	-1,400,000	-1,200,000	-20,600,000	-500,000	-500,000	-300,000	-9,700,000
repurchase of common stock							-66,300,000	0	0	-350,000,000	-1,000,800,000	-1,000,000,000	-500,100,000	-106,500,000					-34,300,000	0	0	-100,000,000	0	-69,500,000								0	0	-2,000,000,000
cash dividends paid by joint venture to noncontrolling interest			0	0
payment of deferred purchase consideration			0	0	0	-500,000	0	-800,000	-400,000	-1,700,000	-1,000,000	-500,000	-1,800,000	-1,200,000	-2,700,000	-9,500,000	-1,800,000	-7,900,000	-36,500,000	-18,500,000	-8,900,000	-21,100,000
net cash from financing activities	-147,800,000	-235,800,000	49,400,000	98,200,000	50,000,000	-46,700,000	-31,500,000	61,800,000	63,300,000	-381,200,000	-963,500,000	-926,800,000	-482,100,000	-199,900,000	18,600,000	68,300,000	58,300,000	-102,200,000	-39,800,000	85,200,000	47,600,000	-178,700,000	50,800,000	1,200,000	-178,600,000	-41,800,000	33,700,000	57,700,000	43,200,000	-8,300,000	-243,100,000	83,600,000	124,700,000	-1,878,300,000	-100,000	109,700,000	200,500,000	248,400,000	-23,800,000	112,400,000	38,800,000	66,000,000	116,400,000	94,600,000	-974,000,000	70,600,000	29,600,000				73,100,000	-121,900,000	64,900,000	103,100,000		-70,200,000	-96,700,000	61,600,000	-122,600,000	-32,500,000	38,100,000	124,700,000	40,920,000	29,887,000	7,458,000	-144,434,000	3,196,000	35,886,000	24,638,000	34,260,000	30,091,000	39,528,000	27,101,000	22,127,000	11,493,000	13,537,000
effect of exchange rate changes on cash, cash equivalents, and restricted cash	1,000,000	-4,500,000	8,300,000	-12,200,000	-3,700,000	6,800,000	-5,400,000	1,700,000	5,200,000	1,800,000	-2,500,000	1,900,000	2,200,000	3,800,000	-1,100,000	300,000	-3,400,000	800,000	-600,000	-400,000	-800,000	-800,000	700,000	-1,600,000	-100,000	-1,200,000	600,000	-100,000	-1,600,000	1,000,000
net increase in cash, cash equivalents, and restricted cash	829,300,000	554,800,000	-383,900,000	-620,500,000	199,700,000	97,000,000	-852,800,000	165,300,000	1,291,800,000	565,100,000	46,700,000	2,800,000	433,000,000	-187,800,000	-55,800,000	-268,800,000	212,900,000	-220,800,000	252,800,000	-666,500,000	813,400,000	56,200,000	198,000,000	179,300,000	-85,400,000	-18,700,000	-113,900,000	-195,200,000	228,800,000	326,500,000
cash, cash equivalents, and restricted cash, beginning of period	0	2,062,400,000		0	0	2,770,100,000		0	0	1,600,700,000		0	0	1,306,000,000		0	0	1,638,500,000		0	0	1,182,600,000		0	0	909,400,000		0	0	663,200,000
cash, cash equivalents, and restricted cash, end of period	829,300,000	2,617,200,000		-620,500,000	199,700,000	2,867,100,000		165,300,000	1,291,800,000	2,165,800,000		2,800,000	433,000,000	1,118,200,000		-268,800,000	212,900,000	1,417,700,000		-666,500,000	813,400,000	1,238,800,000		179,300,000	-85,400,000	890,700,000		-195,200,000	228,800,000	989,700,000
gain on sale of business											0	0	0	-3,800,000
(gain) loss on investments and amortization of investment discounts and premiums
purchases of investments
cash, cash equivalents, and restricted cash, beginning of year
cash, cash equivalents, and restricted cash, end of year
loss on investments, accretion of discounts, and amortization of premiums on investments							-7,400,000	300,000	9,500,000	4,900,000																		-1,500,000	0	4,700,000		5,400,000	5,300,000	6,100,000								5,400,000
gain on investments, accretion, and amortization												9,600,000	7,800,000	26,000,000		2,200,000	8,300,000	-12,600,000		-61,800,000	-2,600,000	200,000		-5,000,000	-400,000	-1,200,000
purchase of property, plant, and equipment and intellectual property												-169,100,000	-130,500,000	-95,100,000	-150,900,000	-68,300,000	-75,700,000	-58,600,000	-61,900,000	-64,400,000	-110,000,000	-105,200,000	-142,000,000	-86,700,000	-82,100,000	-114,800,000		-47,000,000	-44,800,000	-40,100,000
acquisition of businesses, net of cash, and other investing activities												200,000
acquisition of businesses, net of cash															0	0	0	-8,700,000	0	0	0	-37,700,000	-27,900,000	-33,000,000	2,500,000	-1,300,000	-27,800,000																	-1,700,000
capital contribution from noncontrolling interest																							0	0	0	10,000,000
gain on investment, accretion of discounts, and amortization of premiums on investments
other financing activities																								-7,500,000	-3,000,000	-2,000,000	1,700,000	0	0	8,000,000	0
amortization of contract acquisition asset																									3,100,000	2,800,000	2,700,000	2,600,000	2,600,000	2,700,000
changes in operating assets and liabilities, net of effects of acquisition:
loss on investment, accretion of discounts, and amortization of premiums on investments
income tax benefits from employee stock plans																																			4,200,000	7,300,000	7,500,000	10,800,000	-2,700,000	6,900,000	9,100,000	8,200,000	6,200,000	6,800,000
purchase of property, plant and equipment, and intellectual property																															-31,000,000	-51,400,000												-13,800,000
repurchase common stock
acquisition of business, net of cash
changes in operating assets and liabilities:
repurchase and retirement of common stock																																			-34,400,000	0	0	-8,100,000	-84,200,000	-35,500,000	-49,300,000	-14,700,000	0	0			0	-693,800,000	-269,700,000	-145,700,000	-53,200,000	-169,900,000			0	-181,100,000	-139,100,000	-11,600,000	-139,700,000				0	0	0	-150,000,000
effect of exchange rate changes on cash and cash equivalents																															100,000	1,000,000	500,000	500,000		100,000	0	900,000	-100,000	-500,000	300,000	-1,200,000	200,000	-1,100,000	0	300,000		500,000	100,000	-400,000	300,000	0	-300,000	200,000		-400,000	0	800,000	-400,000	700,000	-600,000	-500,000	-62,000	272,000	461,000	-366,000	-120,000	-484,000	118,000	597,000	120,000	147,000			164,000	10,000
net increase in cash and cash equivalents																															-226,800,000	178,500,000	-12,100,000	-328,000,000	15,000,000	-171,900,000	213,000,000	265,900,000	-153,600,000	-47,200,000	214,300,000	100,800,000				31,900,000	195,300,000	154,100,000	5,200,000	-126,200,000	157,500,000	-88,200,000	158,500,000	-139,900,000		-83,800,000	-67,800,000	170,000,000	-102,200,000	-38,000,000	106,400,000	92,200,000	15,342,000	32,674,000	76,816,000	-98,018,000	-32,991,000	4,591,000	-7,785,000	107,983,000	36,432,000	20,681,000	12,957,000	18,365,000	-19,055,000	22,384,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
changes in operating assets and liabilities
cash and cash equivalents, beginning of period																																0	0	1,036,600,000		0	0	714,600,000		0	0	600,300,000		0	0	782,100,000		0	0	553,700,000		0	0	465,800,000		0	0	279,800,000		0	0	221,400,000		0	0	194,623,000		0	0	122,825,000	0	0	0	34,390,000	0	0
cash and cash equivalents, end of period																																178,500,000	-12,100,000	708,600,000		-171,900,000	213,000,000	980,500,000		-47,200,000	214,300,000	701,100,000		-14,600,000	-306,400,000	814,000,000		154,100,000	5,200,000	427,500,000		-88,200,000	158,500,000	325,900,000		-83,800,000	-67,800,000	449,800,000		-38,000,000	106,400,000	313,600,000		32,674,000	76,816,000	96,605,000		4,591,000	-7,785,000	230,808,000	36,432,000	20,681,000	12,957,000	52,755,000	-19,055,000	22,384,000
purchase of property, plant and equipment																																		-53,000,000		-15,100,000	-11,400,000	-9,600,000
excess tax benefit from employee stock plans																																			-4,600,000	-9,200,000	-12,000,000	-18,300,000	-1,100,000	-11,900,000	-11,100,000	-10,200,000
purchase of property, plant and equipment, intellectual property
acquisition of business, net of cash acquired
loss on investments, accretion of discounts and amortization of premiums on investments																																				8,900,000	9,100,000	8,300,000		6,800,000
inventories																																							20,000,000	3,100,000	-5,900,000	-27,900,000	13,700,000	-1,600,000	-18,500,000	-20,400,000		-34,700,000	-37,400,000	-15,800,000
depreciation																																								17,400,000	14,900,000	14,000,000	13,800,000	13,400,000	12,500,000	12,300,000	13,400,000	11,300,000	10,900,000	10,400,000	9,500,000	10,000,000	7,700,000	7,500,000		7,100,000	6,900,000	6,900,000	6,300,000	6,000,000	5,800,000	5,600,000	4,798,000	5,072,000	4,864,000	4,225,000	3,946,000	3,968,000	3,580,000	3,139,000	2,995,000	2,955,000	2,638,000	2,423,000	2,613,000	2,174,000
purchase of property, plant and equipment, and acquired intellectual property																																								-28,500,000
proceeds from issuance of common stock																																									77,300,000	80,200,000	107,600,000	85,500,000	24,200,000	66,300,000	22,700,000	25,800,000	22,800,000	89,300,000	86,800,000	38,000,000	55,600,000	82,900,000		90,400,000	31,700,000	59,500,000	8,200,000	17,000,000	23,400,000	92,500,000	24,961,000	21,676,000	6,488,000	5,566,000	2,684,000	18,675,000	8,299,000	15,019,000	14,368,000	21,354,000	10,597,000	9,660,000	3,296,000	4,194,000
purchase of property, plant and equipment and acquired intellectual property																																										-19,200,000
loss of investment, accretion of discounts and amortization of premiums on investments
loss on investment, accretion of discounts and amortization of premiums on investments																																												5,500,000
excess tax benefit from share-based compensation																																												-9,100,000	-1,800,000	-4,300,000
net decrease in cash and cash equivalents																																												-14,600,000
supplemental non-cash investing activities:
demonstration equipment transfers from inventories to property, plant and equipment
accretion of discounts and amortization of premiums on investments																																														8,100,000	8,200,000	8,400,000	10,400,000	9,800,000	9,300,000	8,600,000	8,200,000	7,000,000
income tax benefits from employee stock option plans																																														2,100,000	4,800,000	3,900,000	5,900,000	19,900,000	39,100,000	10,100,000	24,500,000	20,200,000		15,100,000	9,500,000	11,600,000		8,800,000	13,400,000	27,300,000
purchase of property, plant and equipment, intellectual property and business																																														-20,600,000	-28,900,000	-34,000,000	-25,000,000	-16,700,000	-88,700,000
other accrued liabilities																																																			-2,200,000								-11,500,000				293,000						5,482,000	2,089,000			4,458,000	-2,209,000
supplemental cash flow information:
income taxes paid
excess tax benefit from stock-based compensation																																																-4,600,000	-5,900,000	-20,600,000	-39,500,000	-10,000,000	-24,500,000	-20,200,000	103,700,000	-20,500,000	-10,700,000	-13,700,000	-8,900,000	-9,400,000	-14,700,000	-32,200,000	-15,959,000	-8,211,000			-512,000	-17,211,000	-16,339,000	-19,241,000	-15,723,000	-18,174,000	-16,504,000	-12,467,000
acquisition-related restricted cash
net cash from provided by financing activities																																																	-241,000,000	-35,800,000
stock-based compensation expense																																																		38,200,000	38,300,000	47,300,000																								6,950,000
accrued liabilities																																																					6,700,000	-4,700,000			13,900,000	-7,400,000			50,400,000	-14,100,000			22,600,000	485,000
purchase of property and equipment, intellectual property and business																																																					-13,800,000	-49,800,000
net income .
depreciation .
amortization of intangible assets.
deferred income taxes .
share-based compensation expense of stock options and employee stock purchases
excess tax benefit from stock-based compensation.
income tax benefits related to stock option exercises
other non-cash items
inventory.
accounts payable.
deferred revenue.
other accrued liabilities.
net cash from operating activities.
purchase of investments.
proceeds from sales and maturities of investments.
purchase of property and equipment and acquisition of intellectual property																																																							-15,200,000	-14,500,000	-38,500,000	-14,700,000	-9,400,000	-50,100,000	-20,300,000	-16,200,000	-7,722,000	-5,360,000	-12,854,000	-27,480,000
net cash from investing activities.
proceeds from issuance of common stock, net.
net cash from financing activities.
effect of exchange rate changes on cash and cash equivalents.
net increase in cash and cash equivalents.
cash and cash equivalents, beginning of year.
cash and cash equivalents, end of year.
proceeds from sales and maturities of investments																																																								299,800,000	352,600,000	266,700,000	259,500,000	358,800,000	274,800,000	111,800,000	107,818,000	131,548,000	168,269,000	117,855,000	40,897,000	87,315,000	214,792,000	191,139,000	173,165,000	124,457,000	97,824,000	80,506,000	48,773,000	51,011,000
gain on sale of investments																																																																							0
income tax benefits related to an acquisition
income tax benefits from employee stock option plans and acquisition																																																																7,870,000	769,000	-54,000		17,360,000	17,962,000	20,056,000		24,861,000	17,755,000	14,154,000
acquisition of property and equipment																																																																						-6,949,000	-8,084,000	-5,069,000	-4,398,000	-2,705,000	-3,807,000	-2,072,000
licensing and purchase of intellectual property
capital expenditures and acquisitions of intellectual property																																																																				-20,996,000
licensing and purchase of patents
repayment of notes payable
acquisition of investments in exchange for stock with a cross-licensing agreement
licensing of patents																																																																											0	0
amortization of deferred compensation and stock compensation
supplemental disclosure of cash flow information:
interest paid
non-cash investing activity:
acquisition of investments in connection with a cross-licensing agreement
excess tax benefits from stock-based compensation																																																																												-9,310,000
acquisition related tax benefits																																																																												1,582,000
release of restricted cash																																																																												0
benefit for doubtful accounts
adjustments to reconcile net income to net cash
provided by operating activities:
acquisition of patent
depreciation and amortization
loss on sales of property and equipment
amortization/impairment of intangible assets
prepaids
other assets
restructuring accrual
disposition of property and equipment
acquisition of private equity investments
increase in restricted cash
common stock issued in connection with acquisition of business
benefit for doubtful accounts and write-offs
income tax benefit from stock option exercises
accrued royalty expense
purchase of short-term investments
proceeds from sales and maturities of short-term investments
proceeds from notes payable
benefit from doubtful accounts
loss on sales of fixed assets
prepaid expenses
warranty accrual
release of restricted cash equivalents
increase in restricted cash equivalents
proceeds from sales of short-term investments
proceeds from maturities of short-term investments

We provide you with 20 years of cash flow statements for Intuitive Surgical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Intuitive Surgical stock. Explore the full financial landscape of Intuitive Surgical stock with our expertly curated income statements.

The information provided in this report about Intuitive Surgical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.